Mollie Leoni, Chief Medical Officer at Kura Oncology, Inc. (KURA), sold 41,250 shares at $10.50 ($440K) on 2026-09-28, disclosed to the SEC on 2026-09-29.
Scheduled sale ($440k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.50 | 12,448 | $131K | 29.7% |
| 2 | $10.75 | 28,802 | $310K | 70.3% |
| Total | $10.67 avg | 41,250 | $440K | 100% |
| Filing → |
| KURA | SELL | 2025-11-14 | $346K | — | Filing → |
| KURA | SELL | 2025-09-29 | $220K | — | Filing → |
| KURA | SELL | 2025-01-28 | $39K | — | Filing → |